Novo Nordisk says FDA rejects application for approval of long-acting insulin products

Feb 10, 2013 | Posted by: roboblogger | Full story: Daily News

Novo Nordisk AS says the Food and Drug Administration rejected its applications for approval of once-per-day insulin drugs to treat diabetes.

•••
•••
Enter and win $5000
•••
•••